Germline RAD51C Mutations Confer Susceptibility to Ovarian Cancer

Overview

Journal Nat Genet

Specialty Genetics

Date 2012 Apr 28

PMID 22538716

Citations 109

Authors

Chey Loveday

Clare Turnbull

Elise Ruark

Rosa Maria Munoz Xicola

Emma Ramsay

Deborah Hughes

Margaret Warren-Perry

Katie Snape

Diana Eccles

D Gareth Evans

Martin Gore

Anthony Renwick

Sheila Seal

Antonis C Antoniou

Nazneen Rahman

Affiliations

Soon will be listed here.

Citing Articles

Significantly increased load of hereditary cancer-linked germline variants in infertile men.

Valkna A, Juchnewitsch A, Polluaas L, Lillepea K, Tjagur S, Dutta A Hum Reprod Open. 2025; 2025(2):hoaf008.

PMID: 40060932 PMC: 11889456. DOI: 10.1093/hropen/hoaf008.

Giant Ovarian Tumors in Young Women: Diagnostic and Treatment Challenges-A Report of Two Cases and Narrative Review of the Recent Literature.

Melnyk M, Starczewski A, Nawrocka-Rutkowska J, Gorzko A, Melnyk B, Szydlowska I J Clin Med. 2025; 14(4).

PMID: 40004767 PMC: 11856845. DOI: 10.3390/jcm14041236.

The Role of Tumor Biomarkers in Tailoring the Approach to Advanced Ovarian Cancer.

Tonti N, Golia DAuge T, Cuccu I, De Angelis E, DOria O, Perniola G Int J Mol Sci. 2024; 25(20).

PMID: 39457020 PMC: 11508316. DOI: 10.3390/ijms252011239.

Mechanism of BCDX2-mediated RAD51 nucleation on short ssDNA stretches and fork DNA.

Akita M, Girvan P, Spirek M, Novacek J, Rueda D, Prokop Z Nucleic Acids Res. 2024; 52(19):11738-11752.

PMID: 39268578 PMC: 11514458. DOI: 10.1093/nar/gkae770.

Cancer risks among first-degree relatives of women with a genetic predisposition to breast cancer.

Xiao Q, Mao X, Ploner A, Grassmann F, Rodriguez J, Eriksson M J Natl Cancer Inst. 2024; 116(6):911-919.

PMID: 38366028 PMC: 11160497. DOI: 10.1093/jnci/djae030.

References

Ahmed M, Rahman N . ATM and breast cancer susceptibility. Oncogene. 2006; 25(43):5906-11. DOI: 10.1038/sj.onc.1209873. View

Romero A, Perez-Segura P, Tosar A, Garcia-Saenz J, Diaz-Rubio E, Caldes T . A HRM-based screening method detects RAD51C germ-line deleterious mutations in Spanish breast and ovarian cancer families. Breast Cancer Res Treat. 2011; 129(3):939-46. DOI: 10.1007/s10549-011-1543-x. View

Thompson E, Boyle S, Johnson J, Ryland G, Sawyer S, Choong D . Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients. Hum Mutat. 2011; 33(1):95-9. DOI: 10.1002/humu.21625. View

Zheng Y, Zhang J, Hope K, Niu Q, Huo D, Olopade O . Screening RAD51C nucleotide alterations in patients with a family history of breast and ovarian cancer. Breast Cancer Res Treat. 2010; 124(3):857-61. DOI: 10.1007/s10549-010-1095-5. View

Meindl A, Hellebrand H, Wiek C, Erven V, Wappenschmidt B, Niederacher D . Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene. Nat Genet. 2010; 42(5):410-4. DOI: 10.1038/ng.569. View

Levy-Lahad E . Fanconi anemia and breast cancer susceptibility meet again. Nat Genet. 2010; 42(5):368-9. DOI: 10.1038/ng0510-368. View

Pelttari L, Heikkinen T, Thompson D, Kallioniemi A, Schleutker J, Holli K . RAD51C is a susceptibility gene for ovarian cancer. Hum Mol Genet. 2011; 20(16):3278-88. DOI: 10.1093/hmg/ddr229. View

Loveday C, Turnbull C, Ramsay E, Hughes D, Ruark E, Frankum J . Germline mutations in RAD51D confer susceptibility to ovarian cancer. Nat Genet. 2011; 43(9):879-882. PMC: 4845885. DOI: 10.1038/ng.893. View

Silvestri V, Rizzolo P, Falchetti M, Zanna I, Masala G, Palli D . Mutation screening of RAD51C in male breast cancer patients. Breast Cancer Res. 2011; 13(1):404. PMC: 3109583. DOI: 10.1186/bcr2823. View

10.

Wong M, Nordfors C, Mossman D, Pecenpetelovska G, Avery-Kiejda K, Talseth-Palmer B . BRIP1, PALB2, and RAD51C mutation analysis reveals their relative importance as genetic susceptibility factors for breast cancer. Breast Cancer Res Treat. 2011; 127(3):853-9. DOI: 10.1007/s10549-011-1443-0. View

11.

Vuorela M, Pylkas K, Hartikainen J, Sundfeldt K, Lindblom A, von Wachenfeldt Wappling A . Further evidence for the contribution of the RAD51C gene in hereditary breast and ovarian cancer susceptibility. Breast Cancer Res Treat. 2011; 130(3):1003-10. DOI: 10.1007/s10549-011-1677-x. View

12.

Pang Z, Yao L, Zhang J, Ouyang T, Li J, Wang T . RAD51C germline mutations in Chinese women with familial breast cancer. Breast Cancer Res Treat. 2011; 129(3):1019-20. DOI: 10.1007/s10549-011-1574-3. View

13.

Akbari M, Tonin P, Foulkes W, Ghadirian P, Tischkowitz M, Narod S . RAD51C germline mutations in breast and ovarian cancer patients. Breast Cancer Res. 2010; 12(4):404. PMC: 2949649. DOI: 10.1186/bcr2619. View

14.

Seal S, Thompson D, Renwick A, Elliott A, Kelly P, Barfoot R . Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles. Nat Genet. 2006; 38(11):1239-41. DOI: 10.1038/ng1902. View

15.

Clague J, Wilhoite G, Adamson A, Bailis A, Weitzel J, Neuhausen S . RAD51C germline mutations in breast and ovarian cancer cases from high-risk families. PLoS One. 2011; 6(9):e25632. PMC: 3182241. DOI: 10.1371/journal.pone.0025632. View